Ernexa Therapeutics (ERNA) Current Leases (2016 - 2025)
Historic Current Leases for Ernexa Therapeutics (ERNA) over the last 16 years, with Q3 2025 value amounting to $206000.0.
- Ernexa Therapeutics' Current Leases rose 248.76% to $206000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $206000.0, marking a year-over-year increase of 248.76%. This contributed to the annual value of $207000.0 for FY2024, which is 9065.88% down from last year.
- Ernexa Therapeutics' Current Leases amounted to $206000.0 in Q3 2025, which was up 248.76% from $217000.0 recorded in Q2 2025.
- Ernexa Therapeutics' 5-year Current Leases high stood at $4.3 million for Q2 2024, and its period low was $149000.0 during Q1 2022.
- In the last 5 years, Ernexa Therapeutics' Current Leases had a median value of $291179.5 in 2021 and averaged $791078.2.
- In the last 5 years, Ernexa Therapeutics' Current Leases surged by 236589.6% in 2024 and then plummeted by 9491.33% in 2025.
- Ernexa Therapeutics' Current Leases (Quarter) stood at $408125.0 in 2021, then fell by 27.72% to $295000.0 in 2022, then surged by 651.19% to $2.2 million in 2023, then tumbled by 90.66% to $207000.0 in 2024, then fell by 0.48% to $206000.0 in 2025.
- Its Current Leases stands at $206000.0 for Q3 2025, versus $217000.0 for Q2 2025 and $213000.0 for Q1 2025.